<DOC>
	<DOCNO>NCT00802113</DOCNO>
	<brief_summary>The sequential combination myeloablative therapy autologous stem cell transplantation ( APBSCT ) follow reduced intensity allogeneic stem cell transplant ( Allo SCT ) post SCT adoptive cellular immunotherapy well tolerated patient refractory recurrent non-Hodgkin 's lymphoma ( NHL ) Hodgkin 's disease ( HD ) .</brief_summary>
	<brief_title>Autologous Allogeneic Transplant Relapsed Lymphoma</brief_title>
	<detailed_description>Lymphomas third common group cancer child adolescent United States . While Hodgkin 's Disease ( HD ) describe many year , subtypes non-Hodgkin 's Lymphomas ( NHL ) recently describe . Non-Hodgkin 's lymphoma traditionally classify low , intermediate high grade base clinical aggressiveness . More recently divide two major subgroup indolent aggressive lymphoma current National Cancer Institute ( NCI/PDQ ) reference . Among child , aggressive histology prevalent include small non-cleaved cell lymphoma , lymphoblastic lymphoma , diffuse large cell lymphoma . The common histologic classification childhood non-Hodgkin 's lymphoma past 30 year include morphological schema develop Rappaport , morphologically immunologically base schema Lukes Collins , Kiel classification , prognostic sub-groupings National Cancer Institute 's Working Formulation , recently develop classification utilizes morphological , immunophenotypic genetic information Revised European-American Lymphoma ( REAL ) classification .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>Patient must adequate organ function Adequate renal function define : 1 . Serum creatinine less equal 2.0 x normal , 2 . Creatinine clearance radioisotope GFR &gt; = 40 ml/min/m2 &gt; 60 ml/min/1.73 m2 equivalent GFR determine institutional normal range Adequate liver function define : 1 . Total bilirubin &lt; 2.0 x normal ; 2 . SGOT ( AST ) SGPT ( ALT ) &lt; 5.0 x normal Adequate cardiac function define : 1 . Shortening fraction &gt; 27 % echocardiogram , 2 . Ejection fraction &gt; 47 % radionuclide angiogram echocardiogram Adequate pulmonary function define : 1 . DLCO &gt; 50 % pulmonary function test autologous transplant 2 . DLCO &gt; 40 % pulmonary fuction test reduce intensity allogeneic transplant 3 . For child uncooperative , evidence dyspnea rest , exercise intolerance , pulse oximetry &gt; 94 % room air . Disease Status ( Eligibility ) Patients NonHodgkin 's Lymphoma either follow : 1 . Primary induction failure ( failure achieve initial CR ) partial response ( PR ) stable disease ( SD ) reinduction chemotherapy . *All patient require biopsy regardless PET/Gallium result . 2 . Patients 1st PR , 2nd CR , 2nd PR , 2nd SD follow reinduction chemotherapy 3 . Patients 3rd CR , 3rd PR , 3rd SD follow reinduction chemotherapy Patients Hodgkin 's Disease either follow : 1 . Primary induction failure ( failure achieve initial CR ) and/or primary refractory disease . 2 . First relapse 1 . Early relapse ( within 12 month therapy ) ( exclude receive therapy radiation therapy intial therapy ) 2 . Late relapse ( great 12 month therapy ) . Only patient recurrent Stage III IV disease and/or B symptom relapse ( late relapse exclude ) . 3 . Second relapse . 4 . Third relapse . Patients must achieve CR , PR SD reinduction chemotherapy . Patients NHL HD 4th great CR , PR , and/or SD Patients progressive disease ( PD ) unresponsive reinduction chemo , radio , immunotherapy Hodgkin 's Disease late relapse ( discuss ) . Patients posttransplant lymphoproliferative disease follow solid organ transplantation AIDS associate NHL . Patients n't eligible donor Women pregnant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Autologous Stem Cell Transplant</keyword>
	<keyword>Cord Blood Transplant</keyword>
	<keyword>Allogeneic Stem Cell Transplant</keyword>
	<keyword>Relapsed Lymphoma</keyword>
</DOC>